See more : WCT Holdings Berhad (9679.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Hempsana Holdings Ltd. (HMPS.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hempsana Holdings Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Multi-Chem Limited (AWZ.SI) Income Statement Analysis – Financial Results
- CURO Group Holdings Corp. (CUROQ) Income Statement Analysis – Financial Results
- EVe Mobility Acquisition Corp WT (EVE-WT) Income Statement Analysis – Financial Results
- BB Biotech AG (BION.SW) Income Statement Analysis – Financial Results
- Korshynov Mining Plant Public Joint Stock Company (KOGK.ME) Income Statement Analysis – Financial Results
Hempsana Holdings Ltd. (HMPS.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hempsana.ca
About Hempsana Holdings Ltd.
Hempsana Holdings Ltd., a cannabis extraction and purification company, manufactures and sells cannabis derivatives in Canada and internationally. It offers various cannabis derivatives, including distillates and isolates, and crude CBD oil through wholesale channels. The company also provides cannabis extracts, beverages, edibles, vapes pens, tinctures, and topical products. In addition, it offers wholesale distribution, toll processing, and white labelling contract manufacturing services; and as-a-service offerings, including extraction-as-a-service, post-processing-as-a-service, and formulations-as-a-service for cannabis companies. The company was founded in 2018 and is headquartered in Toronto, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 1.41M | 114.72K | 0.00 | 0.00 |
| Cost of Revenue | 1.01M | 66.28K | 15.40K | 0.00 |
| Gross Profit | 400.58K | 48.43K | -15.40K | 0.00 |
| Gross Profit Ratio | 28.42% | 42.22% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 958.80K | 3.59M | 1.39M | 621.15K |
| Selling & Marketing | 45.95K | 313.65K | 75.69K | 261.00 |
| SG&A | 1.00M | 3.90M | 1.47M | 975.63K |
| Other Expenses | 801.01K | 272.49K | 169.29K | 0.00 |
| Operating Expenses | 1.81M | 4.18M | 1.64M | 1.01M |
| Cost & Expenses | 2.81M | 4.24M | 1.64M | 1.01M |
| Interest Income | 0.00 | 133.73K | 28.77K | 9.07K |
| Interest Expense | 108.16K | 133.73K | 28.77K | 0.00 |
| Depreciation & Amortization | 170.90K | 205.74K | 151.28K | 31.60K |
| EBITDA | -1.20M | -3.90M | -1.41M | -978.19K |
| EBITDA Ratio | -84.93% | -3,412.64% | 0.00% | 0.00% |
| Operating Income | -1.40M | -4.12M | -1.63M | -1.01M |
| Operating Income Ratio | -99.37% | -3,591.99% | 0.00% | 0.00% |
| Total Other Income/Expenses | -75.65K | -110.54K | -28.77K | -9.07K |
| Income Before Tax | -1.48M | -4.24M | -1.65M | -1.02M |
| Income Before Tax Ratio | -104.74% | -3,694.78% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 141.11K | 39.69K | 0.00 |
| Net Income | -1.48M | -4.38M | -1.69M | -1.02M |
| Net Income Ratio | -104.74% | -3,817.79% | 0.00% | 0.00% |
| EPS | -0.06 | -0.20 | -0.13 | -0.07 |
| EPS Diluted | -0.06 | -0.20 | -0.13 | -0.07 |
| Weighted Avg Shares Out | 24.13M | 22.28M | 12.56M | 13.61M |
| Weighted Avg Shares Out (Dil) | 24.13M | 22.28M | 12.56M | 13.61M |
Source: https://incomestatements.info
Category: Stock Reports